BioSpace News Archive

Business

Enzyre appoints Dirk Pollet as Chief Executive Officer

Enzyre, which is developing breakthrough ambulant diagnostic technology for coagulation testing, announces today the appointment of Dirk Pollet as Chief Executive Officer.

May 1, 2019
·
3 min read
Genetown

CARB-X launches new Funding Rounds to support the development of antibiotics, vaccines, diagnostics and other life-saving products that target drug-resistant bacteria

CARB-X announced today its 2019 rounds of funding to support the development of antibiotics, vaccines, biotherapeutics, diagnostics and other life-saving products to address the rising threat of drug-resistant bacteria.

May 1, 2019
·
10 min read
Business

James Gartner Joins AssureCare® in a Key Executive Role

AssureCare, the leading provider of healthcare management software and solutions, announced the appointment of James Gartner as its Executive Vice President of Clinical Strategy.

May 1, 2019
·
2 min read
Sareum to Present at BioTrinity 2019 in London

Sareum Holdings plc (AIM:SAR), the specialist small molecule drug development business, announces that its CEO, Dr Tim Mitchell, will give a company presentation at BioTrinity 2019 in London, which takes place from 30 April – 1 May.

May 1, 2019
·
2 min read
Sequana Medical announces acceptance of late-breaking abstract of DSR therapy for volume overload in heart failure at Heart Failure 2019 Congress

Sequana Medical NV (Euronext Brussels: SEQUA), today announces that results from the first-in-human single dose DSR (Direct Sodium Removal) proof-of-concept study for volume overload in heart failure have been selected for oral presentation in the late-breaking abstract session at Heart Failure 2019 on 27 May 2019

May 1, 2019
·
7 min read
In the United States, spending on hospital-based maternity care surpasses that of any other country, yet rates of maternal morbidity and mortality are rising, despite declines elsewhere.

The MagMAX Viral/Pathogen Nucleic Acid Isolation Kit is a new automation-ready kit for scalable recovery of RNA and DNA from viral particles and gram-negative bacteria.

May 1, 2019
·
1 min read
Pharm Country

Skyrocketing Pharmaceutical Prices Are Putting Pressure on Healthcare Industry, According to TD Bank Survey

Participants were surveyed at the Becker’s Hospital Review 10th Annual Meeting.

May 1, 2019
·
4 min read
Par Pharmaceutical, Inc. Issues Voluntary Nationwide Recall of One Lot of Mycophenolate Mofetil for Injection, USP Due to the Presence of a Glass Fragment Observed in One Vial of Reconstituted Product

One vial of product was observed containing a glass fragment after reconstitution.

May 1, 2019
·
5 min read
FDA

First FDA-approved vaccine for the prevention of dengue disease in endemic regions

The U.S. Food and Drug Administration announced the approval of Dengvaxia, the first vaccine approved for the prevention of dengue disease caused by all dengue virus serotypes in people ages 9 through 16 who have laboratory-confirmed previous dengue infection and who live in endemic areas.

May 1, 2019
·
5 min read
FDA

FDA approves Dengvaxia® for the prevention of dengue in individuals ages 9 through 16 living in U.S. endemic areas

The U.S. Food and Drug Administration approved Dengvaxia® for the prevention of dengue disease caused by serotypes 1 – 4 of the virus in individuals 9 through 16 years of age living in endemic areas of the U.S. with a laboratory-documented prior infection.

May 1, 2019
·
5 min read